Sarah Howell, MD
Dermatology · Honolulu, HINPI 1467550590
Payments from drug & device makers
Across 1,598 payments — averaging $408.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$220K
- AbbVie$184K
- Regeneron Healthcare Solutions, Inc.$92K
- UCB, Inc.$63K
- Galderma Laboratories, L.p.$36K
- Sanofi$34K
- plus $24K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 454 | $219,954 |
| AbbVie | 353 | $183,993 |
| Regeneron Healthcare Solutions, Inc. | 178 | $92,488 |
| UCB, Inc. | 119 | $62,820 |
| Galderma Laboratories, L.p. | 78 | $35,541 |
| Sanofi | 61 | $34,370 |
| Pfizer | 36 | $4,908 |
| Amgen | 54 | $4,907 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 25 | $3,198 |
| Dermavant Sciences, Inc. | 4 | $2,891 |
| Bristol Myers Squibb | 11 | $2,659 |
| LEO Pharma Inc. | 79 | $1,467 |
| Sun Pharmaceutical Industries Inc. | 22 | $733 |
| E.r. Squibb & Sons, L.L.C. | 23 | $723 |
| Novartis | 41 | $712 |
| Incyte Corporation | 11 | $442 |
| Johnson & Johnson | 13 | $382 |
| Genentech USA, Inc. | 9 | $251 |
| Arcutis Biotherapeutics, Inc. | 9 | $215 |
| Sanofi-aventis U.S. LLC | 3 | $174 |
| Dermira, Inc. | 3 | $163 |
| Janssen Scientific Affairs, LLC | 1 | $105 |
| Organon | 4 | $90 |
| Biofrontera Inc. | 3 | $64 |
| Kyowa Kirin, Inc. | 2 | $48 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Aclaris Therapeutics, Inc. | 1 | $22 |
How this compares
$653,343 in reported general payments places this provider in the 95th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Honolulu
- Douglas JohnsonHonolulu$704K
- Ryan SatoHonolulu$226K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Kevin DawsonHonolulu$16K
- Dylan LeeHonolulu$15K
- Sarah GrekinHonolulu$13K
- Gregory HerbichHonolulu$12K
- Shelbi Jim OnHonolulu$10K
- Stella MatsudaHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.